Relationship Between TSHR, BRAF and PIK3CA Gene Copy Number Variations and Thyroid Nodules

Overview

Journal Endocrine

Specialty Endocrinology

Date 2021 Jan 11

PMID 33428122

Citations 1

Authors

Xiaoli Shi

Mengying Qu

Xing Jin

Lixiang Liu

Fangang Meng

Hongmei Shen

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aims to investigate the relationship between the TSHR, BRAF, and PIK3CA gene copy number variations (CNVs) and thyroid nodules by analyzing gene CNVs, and to explore the interaction between iodine status and the above genes CNVs in the occurrence of thyroid nodules.

Methods: Three hundred and ninety-five subjects were selected from 3 regions with different iodine status in Shanxi Province of China, including 192 patients with thyroid nodules and 203 healthy controls. The basic information about subjects had been obtained through a questionnaire. B ultrasound was utilized to check thyroid nodules. Blood and urine samples were harvested to detect the thyroid function and urinary iodine concentration. Real-time quantitative polymerase chains reaction (RT-PCR) served to detect CNVs in DNA from human blood.

Results: There was an association between TSHR gene CNV and thyroid nodules (χ = 8.403, P = 0.004). The prevalence of BRAF and PIK3CA gene CNVs was not statistically significant between the case group and the control group. Differences in the TSHR gene CNV rates for cases of the 3 areas were statistically significant (χ = 10.072, P = 0.007). No statistical difference in the prevalence rates of the 3 genes CNVs between diverse characteristics of thyroid nodules was observed. UIC > 300 μg/L (OR = 1.74, 95% CI: 1.02-2.96, P = 0.041) and TSHR gene CNV (OR = 3.53, 95% CI: 1.40-8.92, P = 0.008) were risk factors for thyroid nodules. There was no significant interaction between the UIC and the examined genes CNVs.

Conclusions: TSHR gene CNV and high urinary iodine levels can increase the risk of thyroid nodules. But the interactions between the 3 above genes CNVs and iodine nutrition were not found in the occurrence of thyroid nodules.

Citing Articles

Single-cell and genetic multi-omics analysis combined with experiments confirmed the signature and potential targets of cuproptosis in hepatocellular carcinoma.

Cao F, Qi Y, Wu W, Li X, Yang C Front Cell Dev Biol. 2023; 11:1240390.

PMID: 37745297 PMC: 10516581. DOI: 10.3389/fcell.2023.1240390.

References

Haugen B, Alexander E, Bible K, Doherty G, Mandel S, Nikiforov Y . 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2015; 26(1):1-133. PMC: 4739132. DOI: 10.1089/thy.2015.0020. View

Remonti L, Kramer C, Leitao C, Pinto L, Gross J . Thyroid ultrasound features and risk of carcinoma: a systematic review and meta-analysis of observational studies. Thyroid. 2015; 25(5):538-50. PMC: 4447137. DOI: 10.1089/thy.2014.0353. View

Popoveniuc G, Jonklaas J . Thyroid nodules. Med Clin North Am. 2012; 96(2):329-49. PMC: 3575959. DOI: 10.1016/j.mcna.2012.02.002. View

Giovanella L, DAurizio F, Campenni A, Ruggeri R, Baldari S, Verburg F . Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions. Endocrine. 2016; 54(3):757-761. DOI: 10.1007/s12020-016-1094-3. View

Song J, Zou S, Guo C, Zang J, Zhu Z, Mi M . Prevalence of Thyroid Nodules and Its Relationship with Iodine Status in Shanghai: a Population-based Study. Biomed Environ Sci. 2016; 29(6):398-407. DOI: 10.3967/bes2016.052. View

Mon S, Riedlinger G, Abbott C, Seethala R, Ohori N, Nikiforova M . Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations. Diagn Cytopathol. 2018; 46(5):369-377. DOI: 10.1002/dc.23915. View

Nikiforov Y, Nikiforova M . Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol. 2011; 7(10):569-80. DOI: 10.1038/nrendo.2011.142. View

Xing M . Genetic alterations in the phosphatidylinositol-3 kinase/Akt pathway in thyroid cancer. Thyroid. 2010; 20(7):697-706. PMC: 2935335. DOI: 10.1089/thy.2010.1646. View

Almal S, Padh H . Implications of gene copy-number variation in health and diseases. J Hum Genet. 2011; 57(1):6-13. DOI: 10.1038/jhg.2011.108. View

10.

Abubaker J, Jehan Z, Bavi P, Sultana M, Al-Harbi S, Ibrahim M . Clinicopathological analysis of papillary thyroid cancer with PIK3CA alterations in a Middle Eastern population. J Clin Endocrinol Metab. 2007; 93(2):611-8. DOI: 10.1210/jc.2007-1717. View

11.

Kumorowicz-Czoch M, Madetko-Talowska A, Tylek-Lemanska D, Pietrzyk J, Starzyk J . Identification of deletions in children with congenital hypothyroidism and thyroid dysgenesis with the use of multiplex ligation-dependent probe amplification. J Pediatr Endocrinol Metab. 2014; 28(1-2):171-6. DOI: 10.1515/jpem-2014-0040. View

12.

Jin X, Guan Y, Shen H, Pang Y, Liu L, Jia Q . Copy Number Variation of Immune-Related Genes and Their Association with Iodine in Adults with Autoimmune Thyroid Diseases. Int J Endocrinol. 2018; 2018:1705478. PMC: 5866896. DOI: 10.1155/2018/1705478. View

13.

Pang Y, Guan Y, Jin X, Shen H, Liu L, Jia Q . Association of TSHR Gene Copy Number Variation with TSH Abnormalities. Biol Trace Elem Res. 2018; 186(1):85-90. DOI: 10.1007/s12011-018-1300-7. View

14.

Zhang L, Zhou Y, Cheng C, Cui H, Cheng L, Kong P . Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma. Am J Hum Genet. 2015; 96(4):597-611. PMC: 4385186. DOI: 10.1016/j.ajhg.2015.02.017. View

15.

Du Y, Gao Y, Meng F, Liu S, Fan Z, Wu J . Iodine deficiency and excess coexist in china and induce thyroid dysfunction and disease: a cross-sectional study. PLoS One. 2014; 9(11):e111937. PMC: 4223066. DOI: 10.1371/journal.pone.0111937. View

16.

Liao W, Wan L, Wang T, Chen C, Tse S, Lu C . Association of TLR7 and TSHR copy number variation with Graves' disease and Graves' ophthalmopathy in Chinese population in Taiwan. BMC Ophthalmol. 2014; 14:15. PMC: 3929160. DOI: 10.1186/1471-2415-14-15. View

17.

Sancak S, Jaeschke H, Eren F, Tarcin O, Ozlem T, Guellueoglu B . High prevalence of TSHR/Gsα mutation-negative clonal hot thyroid nodules (HNs) in a Turkish cohort. Horm Metab Res. 2011; 43(8):562-8. DOI: 10.1055/s-0031-1280829. View

18.

Tsai C, Nussinov R . Allosteric activation of RAF in the MAPK signaling pathway. Curr Opin Struct Biol. 2018; 53:100-106. DOI: 10.1016/j.sbi.2018.07.007. View

19.

Ciampi R, Zhu Z, Nikiforov Y . BRAF copy number gains in thyroid tumors detected by fluorescence in situ hybridization. Endocr Pathol. 2005; 16(2):99-105. DOI: 10.1385/ep:16:2:099. View

20.

Santarpia L, El-Naggar A, Cote G, Myers J, Sherman S . Phosphatidylinositol 3-kinase/akt and ras/raf-mitogen-activated protein kinase pathway mutations in anaplastic thyroid cancer. J Clin Endocrinol Metab. 2007; 93(1):278-84. DOI: 10.1210/jc.2007-1076. View